Featured Research

from universities, journals, and other organizations

Yale Researchers Develop Promising AIDS Vaccine

Date:
October 16, 2001
Source:
Yale University
Summary:
Yale researchers have developed an AIDS vaccine that has proved effective in animal studies and holds promise for humans.

Yale researchers have developed an AIDS vaccine that has proved effective in animal studies and holds promise for humans.

Related Articles


"Based on our results, we think it is likely that this vaccine could be an effective AIDS vaccine in humans," said principal investigator John K. Rose, professor of pathology and cell biology at Yale University School of Medicine.

For the past six years, Rose and his team have been developing a common livestock virus as a vaccine vector (a vaccine delivery system). This vector system, which is called VSV (vesicular stomatitis virus), was highly effective in animal models for influenza and measles. Published in the September 7 issue of Cell, the results of two new studies show that vaccination with the VSV vector encoding AIDS virus proteins can protect monkeys from AIDS caused by a virus that is a hybrid between a human AIDS virus and a monkey AIDS virus.

The research team first vaccinated seven monkeys with their new vaccine and then infected them with the AIDS virus. Eight control monkeys were also infected with the AIDS virus, but did not receive the vaccine. "We found that seven out of eight unvaccinated monkeys developed AIDS in an average of five months, while vaccinated monkeys have been AIDS-free for up to 14 months," said Rose.

Rose said that two other studies using DNA vaccine approaches published in Science in the past year demonstrated similar protection, but that those DNA vaccine vectors may not be as practical as VSV.

"An advantage of the VSV vector system over the others is that it does not require multiple injections and instead can be given as nasal drops," said Rose. "In the developing world and areas that have been hit hard with HIV and AIDS, it would be impractical and very expensive to inject millions of people with DNA vaccines. The VSV-based vaccine would be a cost-effective and equally successful alternative to the other vaccines that have been tested. We are truly excited about this advance."

Rose said the next step is to begin preparing for a Phase I safety trial in humans. He will present the current findings at the AIDS Vaccine 2001 Conference in Philadelphia on September 6.

Other authors on the study include first author Nina F. Rose, Linda Buonocore and Anjeanette Roberts of Yale; Preston A. Marx of the Aaron Diamond AIDS Research Center and Tulane University; Amara Luckay of the Aaron Diamond AIDS Research Center; Douglas F. Nixon, Walter J. Moretto and Sean M. Donahoe of the Gladstone Institute of Virology and Immunology and David Montefiori of Duke University.


Story Source:

The above story is based on materials provided by Yale University. Note: Materials may be edited for content and length.


Cite This Page:

Yale University. "Yale Researchers Develop Promising AIDS Vaccine." ScienceDaily. ScienceDaily, 16 October 2001. <www.sciencedaily.com/releases/2001/10/011016070122.htm>.
Yale University. (2001, October 16). Yale Researchers Develop Promising AIDS Vaccine. ScienceDaily. Retrieved October 26, 2014 from www.sciencedaily.com/releases/2001/10/011016070122.htm
Yale University. "Yale Researchers Develop Promising AIDS Vaccine." ScienceDaily. www.sciencedaily.com/releases/2001/10/011016070122.htm (accessed October 26, 2014).

Share This



More Health & Medicine News

Sunday, October 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
Toxin-Packed Stem Cells Used To Kill Cancer

Toxin-Packed Stem Cells Used To Kill Cancer

Newsy (Oct. 25, 2014) — A Harvard University Research Team created genetically engineered stem cells that are able to kill cancer cells, while leaving other cells unharmed. Video provided by Newsy
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins